Literature DB >> 11848459

Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.

Gualtiero Palareti1, Cristina Legnani, Benilde Cosmi, Giuliana Guazzaloca, Claudia Pancani, Sergio Coccheri.   

Abstract

In some patients with previous venous thromboembolism (VTE) D-dimer levels (D-Dimer) tend to increase after oral anticoagulant therapy (OAT) is stopped. The aim of our study was to evaluate the predictive value of D-Dimer for the risk of VTE recurrence after OAT withdrawal. After a first episode of deep vein thrombosis (DVT) of the lower limbs and/or pulmonary embolism (PE), 396 patients (median age 67 years, 198 males) were followed from the day of OAT discontinuation for 21 months. D-dimer was measured on the day of OAT withdrawal (T1), 3-4 weeks (T2) and 3 months (+/- 10 days, T3) thereafter. The main outcome events of the study were: objectively documented recurrent DVT and/or PE. D-dimer was found to be increased in 15.5%, 40.3% and 46.2% of the patients at T1, T2 and T3, respectively. In 199 (50.2%) patients, D-dimer levels were elevated in at least one measurement. During a follow-up of 628.4 years, 40 recurrences were recorded (10.1% of patients; 6.4% patient-years of follow-up). D-dimer was increased in at least one measurement in 28 of these cases, but remained normal in 11 subjects (three of whom had recurrent events triggered by circumstantial factors, three with malignancy-associated factors) (in one subject D-dimer was not measured). The negative predictive value (NPV) of D-dimer was 95.6% (95% CI 91.6-98.1) at T3 and was even higher (96.7%; 95% CI 92.9-98.8) after exclusion of the six recurrences due to circumstantial factors. Only five idiopathic recurrences occurred in the 186 patients with consistently normal D-dimer. In conclusion, D-dimer has a high NPV for VTE recurrence when performed after OAT discontinuation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11848459

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  40 in total

1.  British Thoracic Society guidelines for the management of suspected acute pulmonary embolism.

Authors: 
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

Review 2.  Diagnosis, investigation, and management of deep vein thrombosis.

Authors:  Clive Tovey; Suzanne Wyatt
Journal:  BMJ       Date:  2003-05-31

3.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 4.  Quantitative assessment of elevated D-dimers.

Authors:  Gabriela Barizzi; Lorenzo Alberio
Journal:  Int J Hematol       Date:  2007-12       Impact factor: 2.490

Review 5.  Update in general internal medicine.

Authors:  Toshiko Uchida; Stephen D Persell; David W Baker
Journal:  J Gen Intern Med       Date:  2009-10-28       Impact factor: 5.128

Review 6.  Diagnosis of deep vein thrombosis, and prevention of deep vein thrombosis recurrence and the post-thrombotic syndrome in the primary care medicine setting anno 2014.

Authors:  Jan Jacques Michiels; Janneke Maria Michiels; Wim Moossdorff; Mildred Lao; Hanny Maasland; Gualtiero Palareti
Journal:  World J Crit Care Med       Date:  2015-02-04

Review 7.  [Therapy and secondary prevention of venous thromboembolism with vitamin K antagonists].

Authors:  R M Bauersachs
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

8.  Use of D-dimer testing to determine duration of anticoagulation, risk of cardiovascular events and occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG study.

Authors:  Benilde Cosmi; Cristina Legnani; Alberto Tosetto; Vittorio Pengo; Angelo Ghirarduzzi; Adriano Alatri; Domenico Prisco; Daniela Poli; Armando Tripodi; Gualtiero Palareti
Journal:  J Thromb Thrombolysis       Date:  2009-03-14       Impact factor: 2.300

Review 9.  [Modern anticoagulation. Problems of the proven, hope for the new].

Authors:  R Bauersachs; H K Breddin
Journal:  Internist (Berl)       Date:  2004-06       Impact factor: 0.743

10.  The clinical thrombosis center and clinical thrombologist: a new US health systems paradigm for the management of venous thromboembolic disease.

Authors:  Alex C Spyropoulos; William Haire
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.